News

UNOS helps power global insights in heart and lung transplantation

UNOS helps power global insights in heart and lung transplantation

Collage of illustrative images of data from the UNOS Predictive Analytics tool alongside a doctor talking with woman, and a hand resting on a blanket while getting dialysis

Research & Data

UNOS helps power global insights in heart and lung transplantation

As the Data Coordinating Center for the International Thoracic Organ Transplant Registry, UNOS helps advance research and patient care.

Authored by:
Wida Cherikh, PhD

Established by the International Society for Heart and Lung Transplantation (ISHLT) in 1983, the International Thoracic Organ Transplant Registry is the world’s largest source of thoracic transplant data. UNOS has served as the Registry’s Data Coordinating Center since 1992.

After the European Union implemented its General Data Protection Regulation (GDPR) in 2018, Registry data collection was temporarily paused while a new international data-sharing framework was developed. The Registry was later relaunched under a new agreement, and the 2025 and 2026 ISHLT annual reports are based on data collected through this updated framework.

The Registry’s relaunch has re-established an important source of international transplant data and enabled new analyses based on contemporary transplant practices.

UNOS’ role

As the Registry’s Data Coordinating Center, UNOS:

  • Maintains the system used by Registry participants to submit data
  • Oversees Registry operations and data quality
  • Conducts analyses for annual reports, publications and research

Why this matters

UNOS Research helps turn global transplant data into insights that improve patient care and support research. UNOS collaborates closely with clinicians, researchers and Registry leaders worldwide to support participation and strengthen collaboration. Key analyses include:

  • Tracking long-term survival after heart and lung transplantation
  • Comparing outcomes across regions and patient populations
  • Monitoring trends in donor and recipient characteristics
  • Supporting international research studies and clinical guidelines
  • Producing the annual ISHLT Registry reports used by transplant professionals around the world

Key takeaway

For more than 30 years, UNOS has managed the world’s largest heart and lung transplant registry. Through global data coordination, quality oversight, and analytics, UNOS helps generate evidence that improves transplant care and advances research.

Since the Registry’s relaunch, UNOS has supported the collection and analysis of the data used in the 2025 and 2026 ISHLT annual reports. The 2025 report includes the Registry’s largest international cohort analyses of donation after circulatory death (DCD) heart and lung transplant recipients, providing important insights into this growing donor population.

Looking ahead

UNOS will continue serving as the Registry’s Data Coordinating Center through 2026 and is expected to provide analytical and publication support for the 2027 ISHLT Registry reports. 

About UNOS research

UNOS conducts research as part of its mission to save and transform lives through research, innovation and collaboration.

UNOS Spotlight Banner
Read more

UNOS insights and analysis on healthcare and transplant issues

Read more in UNOS Spotlight

Introducing UNOS One℠ and the new UNOS Marketplace

Introducing UNOS One℠ and the new UNOS Marketplace

Collage of illustrative images of data from the UNOS Predictive Analytics tool alongside a doctor talking with woman, and a hand resting on a blanket while getting dialysis

Innovations & Technology

Introducing UNOS OneSM and the new UNOS Marketplace

UNOS’ new platform connects organ donation and transplant professionals with data, analytics and trusted partners in one easy-to-access location.

UNOS has launched a new way for organ donation and transplantation professionals to access the products, services and solutions that support their lifesaving work.

UNOS One is a cloud-based platform designed to serve as the centralized home for UNOS data products and services, including UNOS Tools. Built with users in mind, the platform offers a clean, intuitive entry point to powerful data and analytics resources that help inform decisions, monitor performance and support continuous improvement across the donation and transplant community.

The launch of UNOS One reflects UNOS’ ongoing commitment to improving the customer experience by bringing UNOS products together in one location, helping save donation and transplant professionals time and allowing them to focus on their work to save lives.

Tools for organ procurement organizations (OPOs) are also available in UNOS One, including UNOS Organ Utilization ToolSM and UNOS OPO Benchmark Report.

Learn more about UNOS One

UNOS Marketplace

UNOS One also features the new UNOS Marketplace, a directory that connects organ donation and transplantation professionals with trusted third-party partners.

UNOS Marketplace is designed to help users discover products and services that support their work. By integrating partner offerings into an environment already used by transplant hospitals and OPOs, UNOS is making it easier for professionals to explore solutions within their existing workflow.

Today, 100% of transplant centers and 100% of OPOs have access to UNOS One, demonstrating the platform’s important role in supporting the daily work of the community.

UNOS Marketplace is intended for a range of professionals, including quality and performance improvement staff and leaders, transplant program administrators and directors, physicians and surgeons, organ procurement and placement coordinators, and clinical support staff.

The goal is simple: Help the organ donation and transplant community find trusted solutions more easily, provide additional value through UNOS One, and support innovation that advances the mission to save and transform lives.

Learn more about UNOS Marketplace

Learn more

Mission-aligned organizations interested in participating in UNOS Marketplace can contact Devin Holland to learn more and secure a spot.

Contact Devin

UNOS Spotlight Banner
Read more

UNOS insights and analysis on healthcare and transplant issues

Read more in UNOS Spotlight

UNOS, NASA and LifeNet partner on successful drone transportation of organ

UNOS, NASA and LifeNet partner on successful drone transportation of organ

Teams from the United Network for Organ Sharing, NASA Langley Research Center and LifeNet Health have successfully completed a groundbreaking study transporting human kidneys by drone beyond visual line of sight, marking a major milestone in the future of organ transportation and transplantation.

The June 5 flights highlight the potential for drone technology to support future innovations in organ transportation, with the goal of improving reliability, reducing transit times, and helping save more lives through transplantation.

During the study, research kidneys were biopsied and placed on preservation pumps before and after the flights to assess whether drone transportation affected organ integrity. Temperature, pressure and altitude were monitored throughout the approximately 15-minute flights. Preliminary findings showed no evidence that the flights negatively affected the organs.

“With more than 100,000 people currently waiting for a lifesaving transplant nationwide, innovation in organ transportation is essential,” said UNOS Interim CEO Mark Johnson. “This successful collaboration represents an important step toward making organ transportation safer, faster and more efficient.”

Organ transplantation is one of the most time-sensitive processes in healthcare. Once recovered, organs have only a limited window of viability, making efficient transportation critical to successful transplantation. Delays can impact organ function, patient outcomes, and whether a transplant can occur at all. Transportation innovation, including the exploration of drone technology, could expand access to transplantation for patients on the waitlist or reduce the time to transplant, ultimately improving patient outcomes.

According to national transplant data, another person is added to the U.S. transplant waiting list every eight minutes, while 13 people die each day waiting for an organ that never arrives. More than 3,000 people in Virginia alone are currently waiting for a lifesaving transplant.

The kidneys used in the study were donated for research by a donor family working with LifeNet Health after it was determined the organs would not be transplanted. Through these gifts, the organizations were able to evaluate how drone transportation may support future advances in transplantation logistics and organ preservation.

While transplantation saves lives today, research donation helps save lives tomorrow. Organs and tissues that cannot be used for transplant can still help scientists improve preservation methods, develop new therapies, and explore future innovations in transplantation and patient care.

“Research donation plays a vital role in advancing medicine and transplantation,” said Rony Thomas, President and CEO of LifeNet Health. “While not every organ can be transplanted, many can still contribute to scientific discovery and innovations that may help save countless lives in the future.”

The study also highlights the broader impact of research donation. A single research donation can support multiple scientific studies and discoveries that may improve transplant outcomes and benefit patients for years to come. Many medical advances used in transplantation today were made possible through the generosity of donors and their families.

Research donation occurs only with proper authorization and under strict ethical and regulatory standards. Families receive clear information about the process and can make informed decisions that honor their loved one’s wishes.

UNOS, NASA, and LifeNet Health continue exploring opportunities to further evaluate drone transportation in operational environments, including transporting research organs between hospitals and airports.

Using AI to identify kidney anatomy issues

Using AI to identify kidney anatomy issues

Collage of illustrative images of data from the UNOS Predictive Analytics tool alongside a doctor talking with woman, and a hand resting on a blanket while getting dialysis

Research & Data

Using AI to identify kidney anatomy issues

About the research

UNOS researchers explored whether artificial intelligence (AI) can help identify anatomical issues in donor kidneys before transplant. The system analyzes photos taken during kidney procurement to see whether the organs appear normal or have structural issues that could affect transplant success.

Using existing OPTN data, the UNOS team built a dataset where each donor had a set of photos, filtering out low-quality or irrelevant images. Donors were labeled as follows:

  • No anatomical issues = both kidneys were successfully transplanted
  • Anatomical issues = at least one organ was refused due to anatomy concerns

UNOS researchers then trained the AI model to review sets of donor photos and predict whether anatomical issues were present. The subject matter experts did not provide the model with any direct guidance–it learned from the images and outcomes alone.

Key findings

The AI model showed promising performance in identifying anatomical issues.

Performance metrics:

Icon
When the model flagged an issue, it was correct about two-thirds of the time.

  • If the model flagged three cases as having anatomical issues, two of the cases would be true instances of anatomical issues, and one would be a “false alarm.”

Icon
The model accurately identified two-thirds of true anatomical issues

  • The model would accurately catch two out of three anatomical issues, and would miss one true case

Why this matters

Deciding whether a donor kidney is suitable for transplant is a critical step in the transplant process.

This research shows that AI could help support clinical decision-making by automatically detecting anatomy issues and improving the consistency of identification.

Improvements in how organs are evaluated could help ensure more patients receive successful transplants.

What’s next

This work showed promising results, but the model still has room for improvement. Potential future work may include:

  • Improving how the AI model is trained so it becomes more accurate
  • Working with clinicians in the transplant community to better define and label anatomical issues

With further development, tools like this could help improve the pre-transplant organ evaluation process and support better outcomes for patients.

About UNOS research

UNOS conducts research as part of its mission to save and transform lives through research, innovation and collaboration.


The data reported here have been supplied by UNOS as the contractor for the Organ Procurement and Transplantation Network (OPTN). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy of or interpretation by the OPTN or the U.S. Government.

This study used data from the Organ Procurement and Transplantation Network (OPTN). The OPTN data system includes data on all donors, wait-listed candidates, and transplant recipients in the US, submitted by the members of the Organ Procurement and Transplantation Network (OPTN). The Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services provides oversight to the activities of the OPTN contractor.

UNOS Spotlight Banner
Read more

UNOS insights and analysis on healthcare and transplant issues

Read more in UNOS Spotlight

Paul Rocheleau joins UNOS Board of Directors

Paul Rocheleau joins UNOS Board of Directors

Today, the United Network for Organ Sharing (UNOS) announced that Paul Rocheleau has joined its Board of Directors.

Rocheleau has decades of experience leading and operating global corporations, life sciences ventures, research-university initiatives and nonprofit entities, and brings a strategic insight that has helped organizations identify opportunities and grow.

He played a significant role in advancing life sciences and high skilled talent development initiatives in Virginia. As co-founder of Virginia Life Science Investments, LLC, Rocheleau helped attract international startups to the Commonwealth and launch early-stage operations. From 1997 to 2023, he helped establish and grow the College of Engineering at Virginia Commonwealth University, where he served on its foundation and as executive director of strategic programs. While with the university, he created industry partnerships, assisted economic development efforts, and secured public and private funding.

“Paul’s extensive leadership involving life science startups, technology commercialization and global business initiatives will bring a valuable perspective to the UNOS board,” said Mark Johnson, interim CEO of UNOS. “His experience guiding complex organizations through periods of growth and innovation will be highly valued as we enhance the ways we serve the organ donation and transplant system.”

Rocheleau retired in 2023 following a distinguished career. He has held senior executive roles including chief executive officer of Albright & Wilson, a London-based multinational chemical company, and chief financial officer of Albemarle Corp., a global specialty chemicals company. In these roles, he developed and implemented disruptive business strategies, commercialized new technology, created strategic partnerships, and secured funding for acquisitions to support rapid growth.

He has served on the boards of public multinational companies, nonprofit organizations and private companies, including Richmond-based Apex Systems Inc.

“I am honored to join the UNOS board and support its mission to save and improve lives,” Rocheleau said. “I look forward to contributing to the organization’s critically important work as it expands and engages partners across a very complex ecosystem that defines the organ donation and transplant community.”

Rocheleau will begin his term on June 1, 2026, serving until September 30, 2029. He was unanimously approved by a full board vote on May 18, 2026.

Notice of Privacy Practices and UNOS Privacy Policies updated

UNOS, NASA and LifeNet partner on successful drone transportation of organ

UNOS is committed to protecting the privacy and confidentiality of the individuals we serve. As part of our ongoing efforts to maintain transparency and ensure compliance with evolving regulatory and operational standards, we have recently revised and updated our Notice of Privacy Practices (NPP) as well as the United Network for Organ Sharing (UNOS) Privacy Policies.

These updates reflect enhancements to how personal and health information is collected, used, shared, and safeguarded within our organization and in coordination with national transplant systems. The revisions also align with current legal requirements and best practices in data protection.

What this means

While our core commitment to privacy remains unchanged, the updated policies provide:

  • Greater clarity on how your information may be used and disclosed
  • Additional details about your privacy rights and choices
  • Updated language reflecting current standards and processes
  • Expanded information regarding data security and protection measures

Review the updated policies

We encourage all patients, donors, families, and visitors to review the revised documents to stay informed about how your information is handled and about your rights regarding that information.

Questions or concerns?

If you have any questions about these updates or how your information is protected, please contact our Privacy Office. We are here to help ensure you feel confident and informed about your privacy. Thank you for your continued trust as we work to uphold the highest standards of privacy and care.